drugset / Trial / NCT02255110
A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 2, single-arm, Japanese multicenter trial to evaluate the safety, tolerability, and efficacy of TH-302 in combination with doxorubicin in subjects with locally advanced unresectable or metastatic soft tissue sarcoma (STS).
Timeline
- Start
- 2014-12-10
- Primary completion
- 2016-01-12
- Completion
- 2016-01-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | 75 mg/m2 | Intravenous |
| Subject | Evofosfamide | Other / unclassified | 300 mg/m2 | Intravenous |